Cresset Announces Appointment of Rob Scoffin as new CEO
News Apr 26, 2010
Cresset announces the appointment of Dr Rob Scoffin as Chief Executive Officer of Cresset Group. Rob joins Cresset from CambridgeSoft where, as Vice President of European Operations, he was responsible for significant growth in CambridgeSoft’s European business. Rob replaces Beatrice Leigh, who will now become non-executive Chairman of the Board.
“The appointment of Rob marks an exciting new chapter for Cresset,” said Andy Vinter, Founder and Chief Scientific Officer of Cresset. “Rob has a long track record of close collaboration with customers and successful commercial growth in the computational chemistry market place.”
Outgoing CEO and Chairman of the Board, Bea Leigh commented, “We are excited to be working with Rob to further accelerate the company’s development and to achieve our aggressive corporate objectives”.
“This is a fantastic opportunity to join an established company with an excellent scientific reputation, and to help drive growth and enhanced commercial success in the future,” said Rob. “The Cresset team has worked hard to create a world-leading portfolio of products, and I am looking forward to helping bring those to new markets.”
Rob has a D.Phil. in chemistry from Oxford and has recently been instrumental in the development of Electronic Lab Notebook systems which he has deployed at several major pharmaceutical companies. Prior to CambridgeSoft, Rob was CEO (Software) for Amedis and Senior Product Manager at Oxford Molecular.
Concept Life Sciences and Alderley Analytical Partner to provide Bioanalytical and DMPK ServicesNews
Companies announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.READ MORE
Toothpaste Ingredient Could Help Fight Drug-Resistant MalariaNews
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.READ MORE